Continuous bioactivity-dependent evolution of an antibiotic biosynthetic pathway
Biosynthetic gene clusters (BGCs) make small molecules with fitness-enhancing activities that drive BGC evolution. Here, the authors show that synthetic biology can leverage bioactivity to achieve continuous evolution of an antibiotic BGC in the lab and improve antibiotic production in a new host.
Guardado en:
Autores principales: | Chad W. Johnston, Ahmed H. Badran, James J. Collins |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e70d674f16914a20ad1827cab565434c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways
por: Thuc M. Le, et al.
Publicado: (2017) -
Kistamicin biosynthesis reveals the biosynthetic requirements for production of highly crosslinked glycopeptide antibiotics
por: Anja Greule, et al.
Publicado: (2019) -
In vivo continuous evolution of genes and pathways in yeast
por: Nathan Crook, et al.
Publicado: (2016) -
The biosynthetic pathway of potato solanidanes diverged from that of spirosolanes due to evolution of a dioxygenase
por: Ryota Akiyama, et al.
Publicado: (2021) -
A revised biosynthetic pathway for the cofactor F420 in prokaryotes
por: Ghader Bashiri, et al.
Publicado: (2019)